Literature DB >> 12009847

Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat.

E Ann Ellis1, Dennis L Guberski, Brenda Hutson, Maria B Grant.   

Abstract

This study investigated the time course of NADH oxidase, a source of superoxide in the vascular endothelium, inducible nitric oxide synthase (iNOS), and peroxynitrite (ONOO(-)) in the BBZ/Wor rat, a spontaneous model of noninsulin dependent diabetes (NIDDM). Colloidal gold-labeled immunocytochemical studies of iNOS and nitrotyrosine, a marker for OONO(-), were done on sections of retinas from male BBZ/Wor rats in which NADH oxidase was localized by cerium derived cytochemistry at three time points: pre-diabetes (prior to the onset of hyperglycemia); new onset diabetes (2-6 days after onset of hyperglycemia); and chronic diabetes (4-18 months after onset of hyperglycemia). Control retinas were from age matched non-diabetic BB(DR)/Wor rats. The percentage of blood vessels positive for NADH oxidase increased significantly (P = 0.05) in new onset (64.2 +/- 6.5%) and chronic diabetes (83.2 +/- 11.4%), as compared to pre-diabetes (25.8 +/- 5.6%) and nondiabetic controls (33.6 +/- 15.9%). The percentage of blood vessels positive for iNOS immunoreactivity was significantly higher in new onset diabetic retinas (69.6 +/- 5.88%, P = 0.0001; 8.9 +/- 3.29 colloidal gold particles (cgp) /50 microm(2)) than in chronic diabetic retinas (49.9 +/- 9.75%; 7.9 +/- 5.12 cgp) and both were significantly higher (P = 0.0001) than in prediabetic (3.7 +/- 0.81%; 0.4 +/- 0.56 cgp) and nondiabetic control retinas (8.7 +/- 4.66%; 1.2 +/- 1.40 cgp). In new onset diabetes, levels of nitrotyrosine immunoreactivity (60.8 +/- 16.91 cgp) were significantly higher (P = 0.0001) than those in chronic diabetes (29.5 +/- 4.31 cgp); both were significantly higher (P = 0.0001) than those in prediabetic (8.2 +/- 1.70 cgp) and nondiabetic retinas (9.0 +/- 1.87 cgp). There was no cumulative increase in nitrotyrosine in the chronic diabetic retinas as a function of time. In rats with diabetes there was disruption of the inner blood-retinal barrier. These results suggest that iNOS and ONOO(-) may contribute to retinal damage in diabetes from the onset of hyperglycemia in NIDDM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009847     DOI: 10.1006/niox.2001.0419

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  28 in total

1.  Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.

Authors:  I Vareniuk; I A Pavlov; I G Obrosova
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

Review 2.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

3.  Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models.

Authors:  I G Obrosova; V R Drel; A K Kumagai; C Szábo; P Pacher; M J Stevens
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

Review 4.  Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.

Authors:  Pál Pacher; Irina G Obrosova; Jon G Mabley; Csaba Szabó
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

5.  Melatonin prevents retinal oxidative stress and vascular changes in diabetic rats.

Authors:  G Ozdemir; Y Ergün; S Bakariş; M Kılınç; H Durdu; E Ganiyusufoğlu
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

6.  Effect of diabetes on transscleral delivery of celecoxib.

Authors:  Narayan P S Cheruvu; Aniruddha C Amrite; Uday B Kompella
Journal:  Pharm Res       Date:  2008-11-06       Impact factor: 4.200

7.  Targets of tyrosine nitration in diabetic rat retina.

Authors:  Xianquan Zhan; Yunpeng Du; John S Crabb; Xiaorong Gu; Timothy S Kern; John W Crabb
Journal:  Mol Cell Proteomics       Date:  2007-12-28       Impact factor: 5.911

8.  Promise of endothelial progenitor cell for treatment of diabetic retinopathy.

Authors:  Ashay D Bhatwadekar; Lynn C Shaw; Maria B Grant
Journal:  Expert Rev Endocrinol Metab       Date:  2010-01

9.  Myogenic tone and reactivity of cerebral arteries in type II diabetic BBZDR/Wor rat.

Authors:  Yagna P R Jarajapu; Dennis L Guberski; Maria B Grant; Harm J Knot
Journal:  Eur J Pharmacol       Date:  2007-10-25       Impact factor: 4.432

10.  Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide.

Authors:  Miao Zhang; Yunzhou Dong; Jian Xu; Zhonglin Xie; Yong Wu; Ping Song; Melissa Guzman; Jiliang Wu; Ming-Hui Zou
Journal:  Circ Res       Date:  2007-12-06       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.